Cogent Biosciences, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Cogent Biosciences, Inc. (COGT) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-10
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$297.00K.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.83M.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.24M, a 4.43% decline year-over-year.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$806.00K.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $195.00K, a 95.50% decline from fiscal 2024.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $4.33M, a 592.33% increase from fiscal 2023.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $626.00K, a 57.87% decline from fiscal 2022.
- Cogent Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.49M, a 554.63% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.54M 10-Q · filed 2026-08-10 | $4.77M derived: sum of 3 quarters · filed 2026-08-10 | $3.97M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.83M 10-Q · filed 2026-05-05 | $5.07M derived: sum of 2 quarters · filed 2026-05-05 | $4.26M derived: sum of 3 quarters · filed 2026-05-05 | $4.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.43M derived: sum of 2 quarters · filed 2026-02-17 | $2.37M derived: sum of 3 quarters · filed 2026-08-10 | $195.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | -$806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$869.00K derived: sum of 2 quarters · filed 2026-08-10 | -$3.04M 10-Q · filed 2025-11-07 | $345.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.23M 10-Q · filed 2026-08-10 | $1.15M derived: sum of 3 quarters · filed 2026-08-10 | $405.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$2.17M 10-Q · filed 2026-05-05 | $1.21M derived: sum of 2 quarters · filed 2026-05-05 | $468.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.06M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.64M derived: sum of 2 quarters · filed 2026-02-17 | $3.23M derived: sum of 3 quarters · filed 2026-02-17 | $4.33M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$154.00K derived: sum of 2 quarters · filed 2025-11-07 | $948.00K 10-Q · filed 2025-11-07 | -$903.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.69M 10-Q · filed 2025-08-05 | -$157.00K derived: sum of 3 quarters · filed 2026-02-17 | $1.64M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-06 | -$749.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.04M derived: sum of 3 quarters · filed 2026-02-17 | $1.41M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$59.00K derived: sum of 2 quarters · filed 2026-02-17 | $310.00K derived: sum of 3 quarters · filed 2026-02-17 | $626.00K 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.16M derived: sum of 2 quarters · filed 2024-11-12 | $2.48M 10-Q · filed 2024-11-12 | $844.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $685.00K 10-Q · filed 2024-08-06 | -$948.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.26M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $316.00K 10-Q · filed 2024-05-07 | -$1.32M derived: sum of 2 quarters · filed 2025-02-25 | $893.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.06M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $577.00K derived: sum of 2 quarters · filed 2025-02-25 | $749.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.49M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.38M derived: sum of 2 quarters · filed 2023-11-07 | $3.12M 10-Q · filed 2023-11-07 | $1.45M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $909.00K 10-Q · filed 2023-08-08 | -$758.00K derived: sum of 3 quarters · filed 2024-02-26 | $613.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $737.00K 10-Q · filed 2023-05-09 | -$930.00K derived: sum of 2 quarters · filed 2024-02-26 | $441.00K derived: sum of 3 quarters · filed 2024-02-26 | $2.36M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$296.00K derived: sum of 2 quarters · filed 2024-02-26 | $1.62M derived: sum of 3 quarters · filed 2024-02-26 | $227.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.29M derived: sum of 2 quarters · filed 2022-11-14 | $1.89M 10-Q · filed 2022-11-14 | $595.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $523.00K 10-Q · filed 2022-08-09 | -$776.00K derived: sum of 3 quarters · filed 2022-08-09 | $553.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$1.39M 10-Q · filed 2022-05-10 | -$2.69M derived: sum of 2 quarters · filed 2022-05-10 | -$1.36M derived: sum of 3 quarters · filed 2022-05-10 | -$336.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $30.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.06M derived: sum of 3 quarters · filed 2022-03-15 | $1.47M 10-K · filed 2022-03-15 |
| 2020-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.35M derived: sum of 2 quarters · filed 2021-11-10 | $2.77M 10-Q · filed 2021-11-10 | $2.30M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.44M 10-Q · filed 2021-08-16 | $972.00K derived: sum of 3 quarters · filed 2021-08-16 | $945.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $414.00K 10-Q · filed 2021-05-12 | -$54.00K derived: sum of 2 quarters · filed 2021-05-12 | -$81.00K derived: sum of 3 quarters · filed 2021-05-12 | $405.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$495.00K derived: sum of 2 quarters · filed 2021-03-16 | -$9.00K derived: sum of 3 quarters · filed 2021-03-16 | $8.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $459.00K derived: sum of 2 quarters · filed 2020-11-09 | $476.00K 10-Q · filed 2020-11-09 | $263.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $486.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $503.00K 10-Q · filed 2020-08-11 | $290.00K derived: sum of 3 quarters · filed 2020-08-11 | -$157.00K derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $17.00K 10-Q · filed 2020-05-11 | -$196.00K derived: sum of 2 quarters · filed 2020-05-11 | -$643.00K derived: sum of 3 quarters · filed 2020-05-11 | -$401.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$660.00K derived: sum of 2 quarters · filed 2020-03-26 | -$418.00K derived: sum of 3 quarters · filed 2020-03-26 | $250.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | -$447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$205.00K derived: sum of 2 quarters · filed 2019-11-12 | $463.00K 10-Q · filed 2019-11-12 | $132.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $910.00K 10-Q · filed 2019-08-12 | $579.00K derived: sum of 3 quarters · filed 2019-08-12 | $841.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $668.00K 10-Q · filed 2019-05-13 | $337.00K derived: sum of 2 quarters · filed 2019-05-13 | $599.00K derived: sum of 3 quarters · filed 2019-05-13 | $720.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$69.00K derived: sum of 2 quarters · filed 2019-03-28 | $52.00K derived: sum of 3 quarters · filed 2019-03-28 | $237.00K 10-K · filed 2019-03-28 |
| 2017-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $383.00K derived: sum of 2 quarters · filed 2018-11-13 | $568.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $306.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $185.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |